eqrx pharma | EQRx to sell to Revolution Medicines after failed bid to

Keyword	CPC	PCC	Volume	Score	Length of keyword
eqrx pharma	0.29	0.7	2778	57	11
eqrx	1.04	0.4	4179	45	4
pharma	1.66	0.7	9487	69	6

Keyword	CPC	PCC	Volume	Score
eqrx pharma	0.87	0.3	2607	65
eqrx pharma stock	1.78	0.4	8270	78
eqrx pharmaceutical	1.4	0.7	367	77

Search Results related to eqrx pharma on Search Engine

EQRx to sell to Revolution Medicines after failed bid to upend US …
biopharmadive.com

https://www.biopharmadive.com/news/eqrx-revolution-medicines-acquisition-cancer-drug-pricing/689523/

WEBAug 1, 2023 · Dive Brief: EQRx, a biotechnology company that sought to disrupt U.S. drug pricing practices, is being sold to cancer drugmaker Revolution Medicines in an all-stock deal, the companies announced Tuesday. EQRx stockholders will receive 7,692,308 Revolution shares in the deal as well an additional $870 million worth of discounted …

DA: 100 PA: 33 MOZ Rank: 59

EQRx to Accelerate Growth with $1.8 Billion Raise through …
businesswire.com

https://www.businesswire.com/news/home/20210806005227/en/EQRx-to-Accelerate-Growth-with-1.8-Billion-Raise-through-Proposed-Combination-with-CM-Life-Sciences-III

WEBAug 6, 2021 · EQRx Overview. EQRx is purpose-built, at scale, to develop and deliver innovative medicines to patients at radically lower prices through a late-stage and growing product pipeline across...

DA: 46 PA: 13 MOZ Rank: 71

EQRx’s Affordable Drugs Strategy Ends in Acquisition by …
medcitynews.com

https://medcitynews.com/2023/08/biotech-acquisition-cancer-eqrx-revolution-medicines/

WEBAug 1, 2023 · Revolution Medicines is acquiring EQRx in an all-stock deal bringing that company’s more than $1 billion in cash. It marks the end for EQRx, a company that aimed to develop and commercialize...

DA: 44 PA: 7 MOZ Rank: 17

EQRx Debuts as Publicly Traded Company to Develop and …
yahoo.com

https://finance.yahoo.com/news/eqrx-debuts-publicly-traded-company-174500894.html

WEBDec 17, 2021 · EQRx Debuts as Publicly Traded Company to Develop and Deliver Innovative Medicines at Radically Lower Prices. Eqrx, Inc. Fri, Dec 17, 2021 5 min read. Business combination with CM Life Sciences...

DA: 9 PA: 47 MOZ Rank: 19

EQRx, gearing up for a price war with big pharma, buys two cancer drugs
biopharmadive.com

https://www.biopharmadive.com/news/eqrx-cancer-drug-deals-g1-therapeutics-hansoh/582168/

WEBJul 23, 2020 · EQRx, a biotech startup formed to drive down drug prices by developing lower-cost alternatives to branded medicines, has acquired two therapies from G1 Therapeutics and Hansoh Pharmaceutical Group. In one deal, the startup paid G1 $20 million up front — and could add $290 million more — for an experimental breast cancer …

DA: 49 PA: 78 MOZ Rank: 96

EQRx Debuts as Publicly Traded Company to Develop and
globenewswire.com

https://www.globenewswire.com/news-release/2021/12/17/2354647/0/en/EQRx-Debuts-as-Publicly-Traded-Company-to-Develop-and-Deliver-Innovative-Medicines-at-Radically-Lower-Prices.html

WEBDec 17, 2021 · EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices. Launched in January 2020, EQRx is...

DA: 23 PA: 57 MOZ Rank: 51

EQRx Resets to Focus on Clinically Differentiated Medicines, …
yahoo.com

https://finance.yahoo.com/news/eqrx-resets-focus-clinically-differentiated-200100488.html

WEBUpdated May 8, 2023 · 12 min read. EQRx, Inc. Company to utilize significant scale of capital and team to advance a pipeline of clinically differentiated, high-value therapies. Prioritizing ...

DA: 68 PA: 15 MOZ Rank: 24

EQRx builds cancer drug pipeline as plans to challenge big pharma …
biopharmadive.com

https://www.biopharmadive.com/news/eqrx-builds-cancer-drug-pipeline-as-plans-to-challenge-big-pharma-take-shap/587846/

WEBOct 27, 2020 · Dive Brief: EQRx, a startup trying to disrupt the pharmaceutical market by developing cheaper alternatives to branded drugs, has licensed two experimental cancer drugs from CStone Pharmaceuticals, a China-based company that has also attracted attention from Pfizer and a few U.S. biotechs.

DA: 48 PA: 41 MOZ Rank: 90

EQRx and Absci Announce Partnership to Discover and Develop …
businesswire.com

https://www.businesswire.com/news/home/20211006005281/en/EQRx-and-Absci-Announce-Partnership-to-Discover-and-Develop-Next-Generation-Protein-Based-Drugs

WEBOct 6, 2021 · EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices. Launched in January 2020, EQRx is...

DA: 38 PA: 29 MOZ Rank: 51

Revolution Medicines Completes Acquisition of EQRx - Yahoo …
yahoo.com

https://finance.yahoo.com/news/revolution-medicines-completes-acquisition-eqrx-141000106.html

WEBREDWOOD CITY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...

DA: 21 PA: 46 MOZ Rank: 12